Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Clinical Subtype | Transcriptional Subtype | Small Molecule | Antibody | Perturbagen Target | Perturbagen Class | Perturbagen Concentration | Perturbagen Conc Unit | Biological Replicate ID | Relative Cell Count | Normalized Growth Rate Inhibition Value | Nominal Division Rate |
---|---|---|---|---|---|---|---|---|---|---|---|---|
ZR-75-1 | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.107 | uM | 12003.167 | 0.8569 | 0.7414 | 1.1158 | |
ZR-75-1 | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.533 | uM | 12003.167 | 0.8827 | 0.7885 | 1.1158 | |
ZR-75-1 | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 2.67 | uM | 12003.167 | 0.8838 | 0.7903 | 1.1158 | |
ZR-75-1 | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 13.3 | uM | 12003.167 | 0.8574 | 0.7423 | 1.1158 | |
ZR-75-1 | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 66.7 | uM | 12003.167 | 0.8508 | 0.7304 | 1.1158 | |
ZR75B | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.0000853 | uM | 11939.154 | 0.9301 | 0.9176 | 1.7246 | |
ZR75B | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.000427 | uM | 11939.154 | 0.9058 | 0.8885 | 1.7246 | |
ZR75B | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.00213 | uM | 11939.154 | 0.9723 | 0.9677 | 1.7246 | |
ZR75B | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.0107 | uM | 11939.154 | 0.8993 | 0.8807 | 1.7246 | |
ZR75B | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.0533 | uM | 11939.154 | 0.9435 | 0.9337 | 1.7246 | |
ZR75B | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.267 | uM | 11939.154 | 0.8805 | 0.8577 | 1.7246 | |
ZR75B | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 1.33 | uM | 11939.154 | 0.9550 | 0.9474 | 1.7246 | |
ZR75B | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 6.67 | uM | 11939.154 | 0.8862 | 0.8647 | 1.7246 | |
ZR75B | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 33.3 | uM | 11939.154 | 0.9173 | 0.9024 | 1.7246 | |
184A1 | NM | Basal | Gefitinib | EGFR | ErbB | 0.0000853 | uM | 9047.132 | 0.9508 | 0.8605 | 0.6985 | |
184A1 | NM | Basal | Gefitinib | EGFR | ErbB | 0.000427 | uM | 9047.132 | 0.9756 | 0.9306 | 0.6985 | |
184A1 | NM | Basal | Gefitinib | EGFR | ErbB | 0.00213 | uM | 9047.132 | 0.8265 | 0.5226 | 0.6985 | |
184A1 | NM | Basal | Gefitinib | EGFR | ErbB | 0.0107 | uM | 9047.132 | 0.7299 | 0.2744 | 0.6985 | |
184A1 | NM | Basal | Gefitinib | EGFR | ErbB | 0.0533 | uM | 9047.132 | 0.6561 | 0.0939 | 0.6985 | |
184A1 | NM | Basal | Gefitinib | EGFR | ErbB | 0.267 | uM | 9047.132 | 0.9837 | 0.9533 | 0.6985 | |
184A1 | NM | Basal | Gefitinib | EGFR | ErbB | 1.33 | uM | 9047.132 | 0.8476 | 0.5783 | 0.6985 | |
184A1 | NM | Basal | Gefitinib | EGFR | ErbB | 6.67 | uM | 9047.132 | 0.7955 | 0.4414 | 0.6985 | |
184A1 | NM | Basal | Gefitinib | EGFR | ErbB | 33.3 | uM | 9047.132 | 0.8234 | 0.5144 | 0.6985 | |
184B5 | NM | Basal | Gefitinib | EGFR | ErbB | 0.0000853 | uM | 9095.049 | 1.0384 | 1.0684 | 1.1202 | |
184B5 | NM | Basal | Gefitinib | EGFR | ErbB | 0.000427 | uM | 9095.049 | 1.0055 | 1.0098 | 1.1202 |